Korea signals,
read at source.
Selected market briefs from Nathan Research Group's Seoul desk, built from local filings, primary-source interviews, and operator context.
Give the razor away, keep the blade.
CLASSYS sells skin-tightening devices to clinics at razor-thin economics, then earns for years on the single-use cartridges every treatment burns. Revenue tripled in five years while operating margin never left 50% — the exact trick the Western rivals who sold 'just the machine' couldn't manage. Two of them went bankrupt proving it.
CLASSYS · May 27, 2026
→
ElectronicsIt's shrinking itself on purpose.
Partron is a Samsung-ecosystem camera-module maker whose revenue has gone nowhere in five years and whose margin just fell to a five-year low. So management is doing something that looks backwards: cancelling roughly a seventh of its own stock — a 5.0-million-share capital reduction on top of two buybacks — into the bottom of the cycle. Read closely and the move is two things at once: a real return of cash to shareholders, and a 76-year-old founder tightening his grip ahead of an unsolved succession.
Partron · Jun 8, 2026
→
Internet InfrastructureThe boring annuity two activists couldn't ignore.
Gabia is the dullest kind of business: a domain registrar, a web-hosting account, a rack of servers — a recurring cloud annuity that bills monthly and rarely makes the news. Yet the market prices its core operating business below zero, because Gabia listed its best subsidiaries separately and the value leaked out. That negative number is the prize. Two activist funds — Miri Capital and Align Partners — quietly bought past the founder, ran a tender offer, and in March 2026 took two board seats to claim it.
Gabia · Jun 10, 2026
→
Auto PartsChasing its biggest customer to Georgia.
PHA owns one thing completely — the system that opens, closes and locks a car's doors — and sells roughly 70% of it to Hyundai and Kia. That moat is also a cage: revenue peaked in 2016 and only re-crossed that mark in 2025, a lost decade rooted in concentration and a China collapse. The answer runs on two engines: a US$67mn plant in Georgia beside Hyundai's new EV Metaplant, and a shift from mechanical latches to powered, electronic closures. Both are real. Both are still unproven.
PHA · Jun 12, 2026
→
Surgical RoboticsIt put the surgeons on the cap table.
Curexo was a sleepy medical-device distributor with a near-zero-debt balance sheet and ₩187bn of cash. It has quietly turned itself into a surgical-robot platform OEM — CUVIS-joint and CUVIS-spine — taking on Stryker's Mako and Zimmer's ROSA not on scale but on an open platform the majors deliberately keep closed. FY2025 was its first clear profit after four loss years. Then, in April 2026, it handed convertible bonds to three named orthopedic surgeons. That is not a financing event. It is a tell about how this business actually grows.
Curexo · Jun 16, 2026
→Trusted by global institutions.
01Private Equity & Venture Capital
500+PE/VC engagements
02Hedge Funds & Asset Managers
50+Hedge fund clients
03Management Consultancies
Top 10Firms served
04Corporate Strategy Teams
200+Strategy projects
05Investment Banks
100+M&A engagements
From deal sourcing to post-acquisition value creation, access Korean industry experts who accelerate your due diligence and portfolio strategy.
Simple. Fast. Precise.
Four steps. One working week, at most. An ontology for moving from a research question to an answered one.
Define Your Inquiry
Share your research question or project scope. Our team clarifies objectives, timeline, and compliance requirements — so nothing is left to assumption.
Pinpoint the Right Expert
We identify and vet the most relevant Korean experts from our curated network — typically presenting qualified profiles within 24 hours.
Engage on Your Terms
Conduct expert calls, surveys, or workshops in your preferred format. We handle scheduling, compliance checks, and all logistics end-to-end.
Insights That Move You Forward
Receive actionable insights that advance your decision. Follow-up engagements and additional expert connections available on demand.
Share your expertise.
Shape global decisions.
Join Korea’s premier expert network and connect with the world’s leading investors, consultancies, and corporations seeking your knowledge.
- Competitive CompensationProfessional-grade consulting fees for your expertise.
- Full FlexibilityEvery engagement is voluntary, scheduled around you.
- Global ExposureWork with leading investors, consultancies, and corporates.
The Korean market moves fast. Stay ahead.
Curated deep dives and regulatory updates from Nathan Research Group.
We value your privacy
We use cookies to understand how our site is used so we can improve it. Necessary cookies are always on. You can accept all, reject all, or choose what to allow. Learn more